Structure-Based Molecular Docking Study of a Designed Cationic Peptide Sequence KRLVAGLIRKLA Against Targeting the Extracellular Domain of HER2 in HER2-Positive Breast Cancer. AMAR 2026, 4 (3), 985-1101. https://doi.org/10.66021/.